![](/img/cover-not-exists.png)
PO10-TU-34 Evaluation of the risk of malignancies in patients with multiple sclerosis treated with subcutaneous interferon beta-1a
E. Alteri, G. Kornmann, M. Stam Moraga, F. Casset-Semanaz, M. MiretVolume:
285
Year:
2009
Language:
english
DOI:
10.1016/s0022-510x(09)70783-x
File:
PDF, 64 KB
english, 2009